Tianjin, China

He Sun

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 10 EPO patents. Top assignees: Tasly Pharmaceutical Group Co., Ltd., Tasly Pharmaceutical Group Co., Ltd.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: He Sun. Retrieved from https://idiyas.com/inventor/he-sun-zeq9tyd7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 91.7


 

Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Inventor He Sun: Revolutionizing Technology in Tianjin

Introduction: He Sun is a visionary inventor based in Tianjin, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: He Sun holds several patents in the areas of artificial intelligence, renewable energy, and advanced manufacturing processes, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, He Sun has worked with leading tech companies and research institutions, spearheading projects that have pushed the boundaries of technological advancement.

Collaborations: He Sun has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and knowledge sharing to drive progress in the tech industry.

Conclusion: Inventor He Sun's relentless pursuit of innovation and his passion for creating technology that shapes the future make him a true pioneer in the field of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…